Search results for "Cardiology"
Choosing a management option for ACS
An expert reviews antiplatelet, antithrombotic, and invasive options.
https://acphospitalist.acponline.org/archives/2020/06/choosing-a-management-option-for-acs.htm
15 Jun 2020
A transfusion threshold for everyone
Evidence indicates restrictive thresholds are better for most inpatients.
https://acphospitalist.acponline.org/archives/2020/06/a-transfusion-threshold-for-everyone.htm
15 Jun 2020
MKSAP quiz on pulmonary embolism
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on pulmonary embolism.
https://acphospitalist.acponline.org/archives/2020/06/mksap-quiz-on-pulmonary-embolism.htm
15 Jun 2020
Cardiomyopathy
Avoid vague terms like unspecified or nonischemic cardiomyopathy in your documentation, and specify the cause whenever possible.
https://acphospitalist.acponline.org/archives/2020/05/coding-corner-cardiomyopathy.htm
15 May 2020
Takotsubo cardiomyopathy
An example case helps explain this clinical syndrome that mimics acute myocardial infarction.
https://acphospitalist.acponline.org/archives/2020/05/expert-analysis-takotsubo-cardiomyopathy.htm
15 May 2020
Therapeutic hypothermia, HAI network, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2020/05/recent-research.htm
15 May 2020
Latest research looks at clots, drug therapies, and pneumonia guidance
Studies offered further support for anticoagulation in patients with COVID-19 but showed no benefit from hydroxychloroquine or lopinavir-ritonavir. The authors of recent pneumonia guidelines explained how the recommendations apply to COVID-19 patients.
https://acphospitalist.acponline.org/weekly/archives/2020/05/13/2.htm
13 May 2020
COVID-19 research looks at effects and risks of potential drug therapies, proning
Trials offered inconclusive evidence about remdesivir, a pilot study found benefits to prone self-positioning for ED patients, and other research quantified the risk of QT prolongation with hydroxychloroquine and azithromycin and provided reassurance about hypertension drugs.
https://acphospitalist.acponline.org/weekly/archives/2020/05/06/1.htm
6 May 2020
coding corner May 2020 • ACP Hospitalist 7 Cardiomyopathy, ...
Other classifications, of course, include the New York Heart Association functional classes I through IV, the American College of Cardiology/American Heart Association structural stages A to D, and the pathophysiological
https://acphospitalist.acponline.org/archives/2020/05/acph-202005-coding-corner-cardiomyopathy_t1.pdf
29 Apr 2020
IDSA guidelines, experts address hydroxychloroquine, other potential COVID-19 therapies
The Infectious Diseases Society of America (IDSA) made recommendations on using drugs to treat COVID-19, while cardiac groups warned about risks of arrhythmias with hydroxychloroquine and azithromycin.
https://acphospitalist.acponline.org/weekly/archives/2020/04/15/1.htm
15 Apr 2020